Can describe the common or important adverse effects, including important drug interactions, of the systemic treatments commonly used in the index dermatological conditions.
Level
This learning outcome is a primary level outcome.
Sessions
This learning outcome is taught in the following sessions:
Assessment
This learning outcome is assessed in the following ways:
- MBBS Pt 4 (Yr 4)
- Section B - Examination
- Section C - Data Interpretation
- Section D - OSCE Examination
